Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) announced the pricing of a public offering with expected total gross proceeds of approximately $12 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE